Literature DB >> 19466578

Cognitive, behavioural and adaptive profiles of children with glutaric aciduria type I detected through newborn screening.

M H Beauchamp1, A Boneh, V Anderson.   

Abstract

BACKGROUND: Glutaric aciduria type I (GA I) is an autosomal recessive disorder of lysine and tryptophan metabolism due to a deficiency in glutaryl-CoA dehydrogenase activity. Recent reports suggest that early diagnosis through newborn screening and initiation of preventive therapy result in improved functional outcome; however, detailed neuropsychological profiles of children with GA I are seldom reported and thus the impact of the disease on cognition, motor abilities and behaviour remains uncertain.
METHOD: We present detailed neuropsychological profiles of three children who were diagnosed with GA I through newborn screening and treated from early age, and one asymptomatic patient diagnosed through cascade screening. A comprehensive battery of standardized tests was administered including measures of intellectual function, attention/memory, executive function, motor skills, speech/language, as well as behavioural and adaptive skills.
RESULTS: The results reveal overall average cognitive outcomes; however, subtle, but significant, fine motor and articulation deficits were observed. The results are discussed with regard to potential links between fine motor deficits and speech impairments in children with GA I. Such difficulties can impact on the child's ability to engage in academic, leisure and daily activities.
CONCLUSIONS: These findings highlight the importance of in-depth assessments of all aspects of neuropsychological function in patients with GA I and provide a basis for future neuropsychological assessment in similar groups of children. In spite of relatively preserved overall functioning, using a broad range of sensitive cognitive and motor measures facilitates the detection of subtle deficits, and allows for planning of early and adequate therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19466578     DOI: 10.1007/s10545-009-1167-z

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  27 in total

Review 1.  Emergency treatment in glutaryl-CoA dehydrogenase deficiency.

Authors:  S Kölker; C R Greenberg; M Lindner; E Müller; E R Naughten; G F Hoffmann
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

2.  Guideline for the diagnosis and management of glutaryl-CoA dehydrogenase deficiency (glutaric aciduria type I).

Authors:  S Kölker; E Christensen; J V Leonard; C R Greenberg; A B Burlina; A P Burlina; M Dixon; M Duran; S I Goodman; D M Koeller; E Müller; E R Naughten; E Neumaier-Probst; J G Okun; M Kyllerman; R A Surtees; B Wilcken; G F Hoffmann; P Burgard
Journal:  J Inherit Metab Dis       Date:  2007-01-03       Impact factor: 4.982

3.  Natural history, outcome, and treatment efficacy in children and adults with glutaryl-CoA dehydrogenase deficiency.

Authors:  Stefan Kölker; Sven F Garbade; Cheryl R Greenberg; James V Leonard; Jean-Marie Saudubray; Antonia Ribes; H Serap Kalkanoglu; Allan M Lund; Begoña Merinero; Moacir Wajner; Mónica Troncoso; Monique Williams; John H Walter; Jaume Campistol; Milagros Martí-Herrero; Melissa Caswill; Alberto B Burlina; Florian Lagler; Esther M Maier; Bernd Schwahn; Aysegul Tokatli; Ali Dursun; Turgay Coskun; Ronald A Chalmers; David M Koeller; Johannes Zschocke; Ernst Christensen; Peter Burgard; Georg F Hoffmann
Journal:  Pediatr Res       Date:  2006-04-26       Impact factor: 3.756

4.  Intracerebral accumulation of glutaric and 3-hydroxyglutaric acids secondary to limited flux across the blood-brain barrier constitute a biochemical risk factor for neurodegeneration in glutaryl-CoA dehydrogenase deficiency.

Authors:  Sven W Sauer; Jürgen G Okun; Gert Fricker; Anne Mahringer; Ines Müller; Linda R Crnic; Chris Mühlhausen; Georg F Hoffmann; Friederike Hörster; Stephen I Goodman; Cary O Harding; David M Koeller; Stefan Kölker
Journal:  J Neurochem       Date:  2006-03-29       Impact factor: 5.372

5.  Management of movement disorders in glutaryl-CoA dehydrogenase deficiency: anticholinergic drugs and botulinum toxin as additional therapeutic options.

Authors:  A P Burlina; G Zara; G F Hoffmann; J Zschocke; A B Burlina
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

6.  Glutaric aciduria type I associated with learning disability.

Authors:  Neela Patil; Santosh Shinde; Sunil Karande; Madhuri Kulkarni
Journal:  Indian J Pediatr       Date:  2004-10       Impact factor: 1.967

7.  Multimodal imaging of striatal degeneration in Amish patients with glutaryl-CoA dehydrogenase deficiency.

Authors:  Kevin A Strauss; Jelena Lazovic; Max Wintermark; D Holmes Morton
Journal:  Brain       Date:  2007-05-03       Impact factor: 13.501

8.  Type I glutaric aciduria, part 2: a model of acute striatal necrosis.

Authors:  Kevin A Strauss; D Holmes Morton
Journal:  Am J Med Genet C Semin Med Genet       Date:  2003-08-15       Impact factor: 3.908

9.  Newborn screening for glutaric aciduria type I in Victoria: treatment and outcome.

Authors:  Avihu Boneh; Miriam Beauchamp; Maureen Humphrey; Jemma Watkins; Heidi Peters; Joy Yaplito-Lee
Journal:  Mol Genet Metab       Date:  2008-04-14       Impact factor: 4.797

10.  Dystonia and dyskinesia in glutaric aciduria type I: clinical heterogeneity and therapeutic considerations.

Authors:  M Kyllerman; O H Skjeldal; M Lundberg; I Holme; E Jellum; U von Döbeln; A Fossen; G Carlsson
Journal:  Mov Disord       Date:  1994-01       Impact factor: 10.338

View more
  8 in total

Review 1.  Proposed recommendations for diagnosing and managing individuals with glutaric aciduria type I: second revision.

Authors:  Nikolas Boy; Chris Mühlhausen; Esther M Maier; Jana Heringer; Birgit Assmann; Peter Burgard; Marjorie Dixon; Sandra Fleissner; Cheryl R Greenberg; Inga Harting; Georg F Hoffmann; Daniela Karall; David M Koeller; Michael B Krawinkel; Jürgen G Okun; Thomas Opladen; Roland Posset; Katja Sahm; Johannes Zschocke; Stefan Kölker
Journal:  J Inherit Metab Dis       Date:  2016-11-16       Impact factor: 4.982

2.  Neurodevelopmental profiles of children with glutaric aciduria type I diagnosed by newborn screening: a follow-up case series.

Authors:  Amy Brown; Louise Crowe; Miriam H Beauchamp; Vicki Anderson; Avihu Boneh
Journal:  JIMD Rep       Date:  2014-12-11

3.  Cognitive and social profiles in two patients with cobalamin C disease.

Authors:  M H Beauchamp; V Anderson; A Boneh
Journal:  J Inherit Metab Dis       Date:  2009-10-15       Impact factor: 4.982

Review 4.  Diagnosis and management of glutaric aciduria type I--revised recommendations.

Authors:  Stefan Kölker; Ernst Christensen; James V Leonard; Cheryl R Greenberg; Avihu Boneh; Alberto B Burlina; Alessandro P Burlina; Marjorie Dixon; Marinus Duran; Angels García Cazorla; Stephen I Goodman; David M Koeller; Mårten Kyllerman; Chris Mühlhausen; Edith Müller; Jürgen G Okun; Bridget Wilcken; Georg F Hoffmann; Peter Burgard
Journal:  J Inherit Metab Dis       Date:  2011-03-23       Impact factor: 4.982

5.  N-acetylcysteine prevents spatial memory impairment induced by chronic early postnatal glutaric acid and lipopolysaccharide in rat pups.

Authors:  Fernanda S Rodrigues; Mauren A Souza; Danieli V Magni; Ana Paula O Ferreira; Bibiana C Mota; Andreia M Cardoso; Mariana Paim; Léder L Xavier; Juliano Ferreira; Maria Rosa C Schetinger; Jaderson C Da Costa; Luiz Fernando F Royes; Michele R Fighera
Journal:  PLoS One       Date:  2013-10-24       Impact factor: 3.240

Review 6.  Quality of life, psychological adjustment, and adaptive functioning of patients with intoxication-type inborn errors of metabolism - a systematic review.

Authors:  Nina A Zeltner; Martina Huemer; Matthias R Baumgartner; Markus A Landolt
Journal:  Orphanet J Rare Dis       Date:  2014-10-25       Impact factor: 4.123

7.  A cross-sectional controlled developmental study of neuropsychological functions in patients with glutaric aciduria type I.

Authors:  Nikolas Boy; Jana Heringer; Gisela Haege; Esther M Glahn; Georg F Hoffmann; Sven F Garbade; Stefan Kölker; Peter Burgard
Journal:  Orphanet J Rare Dis       Date:  2015-12-22       Impact factor: 4.123

8.  Ammonium accumulation and cell death in a rat 3D brain cell model of glutaric aciduria type I.

Authors:  Paris Jafari; Olivier Braissant; Petra Zavadakova; Hugues Henry; Luisa Bonafé; Diana Ballhausen
Journal:  PLoS One       Date:  2013-01-10       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.